Our Leadership

Meet the experienced team guiding Daktari Biotechnology's vision and strategy

Our leadership team brings together decades of experience in biotechnology, pharmaceuticals, research, and business management. With diverse backgrounds and expertise, they guide our company's strategic direction and ensure we remain at the forefront of biotechnology innovation.

Executive Leadership

Dr. James Mwangi

Chief Executive Officer

With over 20 years of experience in biotechnology, Dr. Mwangi leads our strategic vision and operations. He holds a Ph.D. in Molecular Biology from Harvard University and has previously led research teams at major pharmaceutical companies.

Dr. Amina Ochieng

Chief Scientific Officer

Dr. Ochieng oversees our research and development initiatives, bringing expertise in vaccine development. She earned her Ph.D. from MIT and has published extensively in leading scientific journals.

Michael Kamau

Chief Financial Officer

Michael manages our financial strategy and ensures sustainable growth for our research initiatives. He holds an MBA from Stanford and has 15 years of experience in financial management for biotech companies.

Dr. Sarah Njoroge

Chief Operations Officer

Dr. Njoroge ensures operational excellence across all our facilities and research programs. She has a Ph.D. in Biomedical Engineering and previously managed operations for global pharmaceutical companies.

Dr. David Kimani

Chief Technology Officer

Dr. Kimani leads our technology strategy and digital transformation initiatives. He holds a Ph.D. in Bioinformatics and has pioneered several computational approaches to drug discovery.

Grace Wanjiku

Chief Marketing Officer

Grace oversees our marketing and communications strategy. With an MBA from INSEAD, she brings 12 years of experience in healthcare marketing and strategic communications.

Board of Directors

Prof. John Kariuki

Board Chairman

Prof. Kariuki is a distinguished academic and industry leader with extensive experience in biotechnology governance and policy development.

Dr. Elizabeth Mutua

Board Member

Dr. Mutua brings expertise in global health policy and pharmaceutical regulation to our board, having served in senior roles at international health organizations.

Robert Otieno

Board Member

With a background in venture capital and biotech investments, Robert provides valuable financial and strategic guidance to our organization.